Advertisement

Topics

BRIEF-Karolinska Development: Dilafor granted US patent for Phase II drug tafoxiparin

21:07 EST 1 Dec 2016 | Reuters

* Says its portfolio company Dilafor AB, drug development company focusing on development of tafoxiparin for obstetric indications, has been granted U.S. patent protecting its proprietary compound tafoxiparin

Original Article: BRIEF-Karolinska Development: Dilafor granted US patent for Phase II drug tafoxiparin

NEXT ARTICLE

More From BioPortfolio on "BRIEF-Karolinska Development: Dilafor granted US patent for Phase II drug tafoxiparin"

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Obstetrics and gynaecology
Fertility Menopause Obstetrics & Gynaecology Osteoporosis Women's Health Obstetrics and gynaecology comprises the care of the pregnant woman, her unborn child and the management of diseases specific to women. Most consultant...